English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 94201/94201 (100%)
造訪人次 : 81539827      線上人數 : 3271
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋


    請使用永久網址來引用或連結此文件: https://ir.lib.ncu.edu.tw/handle/987654321/103005


    題名: Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer
    作者: 蘇立仁;Chen, Chang-Han;Chang, Alice YW;Li, Shau-Hsuan;Tsai, Hsin-Ting;Shiu, Li-Yen;Su, Li-Jen;Wang, Wen-Lung;Chiu, Tai-Jen;Luo, Sheng-Dean;Huang, Tai-Lin;Chien, Chih-Yen
    貢獻者: 生醫理工學院生醫科學與工程學系
    關鍵詞: Analysis;Aurora Kinase A - genetics;Biomedical and Life Sciences;Biomedicine;Cancer Research;Care and treatment;Cell Cycle Proteins - genetics;Cell Line, Tumor;Cell Movement - genetics;Cell Proliferation - genetics;Cell Survival - genetics;Development and progression;Diagnosis;Gene expression;Gene Expression Regulation, Neoplastic - genetics;Head and Neck Neoplasms - genetics;Humans;Immunohistochemistry;Matrix Metalloproteinases - genetics;Medical research;Medicine, Experimental;Metastasis;Neoplasm Invasiveness - genetics;Nuclear Proteins - genetics;Oncology;Phosphatidylinositol 3-Kinases - genetics;RNA, Messenger - genetics;Signal Transduction - genetics
    日期: 2015-04-12
    上傳時間: 2026-04-23 11:21:43 (UTC+8)
    出版者: BioMed Central Ltd.;London: BioMed Central
    摘要: 摘要: Background Head and neck cancer (HNC) is a highly invasive cancer. Aurora-A has been reported for a number of malignancies. However, the identity of downstream effectors responsible for its aggressive phenotype in HNC remains underinvestigated. Methods The mRNA and protein expression levels of Aurora-A and FLJ10540 were assessed in HNC specimens and cell lines using RT-qPCR, western blot, Oncomine, and microarray database analysis. The downstream molecular mechanisms of Aurora-A were confirmed by RT-qPCR, western blot, luciferase reporter, confocal microscopy analyses, immunoprecipitation, colony formation, cell viability, and xenograft model. Cellular functions in response to Aurora-A-modulated downstream targets such as FLJ10540 and MMPs were examined in vitro and in vivo , including cell growth, motility and chemosensitivity. Aurora-A/FLJ10540/MMPs expression was determined in cancer and adjacent normal tissues from HNC patients by immunohistochemistry approach. Results In the current study, Aurora-A exhibited similar gene expression profiles with FLJ10540 by using accessibly public microarray and Oncomine database analysis, raising the possibility that these molecules might coordinately participate in cancer progression and metastasis of HNC. These two molecules connection were also examined in cell lines and tissues of HNC. Aurora-A overexpression could not only bind to the promoter of FLJ10540 to induce FLJ10540 expression, but also increase both mRNA and protein levels of MMP-7 and MMP-10 in HNC cells. Conversely, depletion of Aurora-A expression by using siRNA or Aurora-A kinase inhibitor, MLN8237, suppressed FLJ10540, MMP-7 and MMP-10 mRNA and protein expressions in vitro and in vivo . In addition, the FLJ10540-PI3K complex was destroyed by inhibition the Aurora-A kinase activity. Forced overexpression of FLJ10540 in Aurora-A-depleted or in MLN8237-treated HNC cells attenuated the effect on cytotoxicity to cisplatin. Elevated Aurora-A expression in HNC cells led to the characteristics of more aggressive malignancy, including enhanced chemoresistance and increased the abilities of proliferation, migration and invasion, which was required for FLJ10540/MMP-7 or FLJ10540/MMP-10 expressions. Finally, immunohistochemical analysis of human HNC specimens showed a significant positively correlation among Aurora-A, FLJ10540, MMP-7 and MMP-10 expressions. Conclusion Together, our findings define a novel mechanism by which Aurora-A promotes cell malignancy, with potential implications for understanding the clinical action of Aurora-A.
    其他題名: Mol Cancer
    出版者: London: BioMed Central
    出版日期: 2015-04-12
    出處: Molecular cancer, 2015-04, Vol.14 (1), p.83-83, Article 83
    資源來源: Publicly Available Content Database
    版權: Chen et al.; licensee BioMed Central. 2015
    版權: COPYRIGHT 2015 BioMed Central Ltd.
    識別號: ISSN: 1476-4598
    識別號: EISSN: 1476-4598
    識別號: DOI: 10.1186/s12943-015-0348-7
    識別號: PMID: 25889801
    顯示於類別:[生醫科學與工程學系] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML16檢視/開啟


    在NCUIR中所有的資料項目都受到原著作權保護.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明